Zymeworks Operating Cash Flow 2011-2026 | ZYME

Annual Operating Cash Flow Zymeworks

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-192 M	-151 M	-81.9 M	24.2 M	219 K	-35.2 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
24.2 M	-192 M	-72.8 M

Quarterly Operating Cash Flow Zymeworks

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-55.4 M	-	-	-	-40.8 M	-	-104 M	-87.4 M	-37.5 M	-	-45.5 M	-34.6 M	-21.3 M	-	-25.9 M	-13.1 M	-17.6 M	-	-38.8 M	-26.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-13.1 M	-104 M	-42.2 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-481 M	-	2.43 %	$ 254 M	Germany
Adagene ADAG	-29.7 M	$ 2.19	7.88 %	$ 123 M	China
Acorda Therapeutics ACOR	-14 M	-	-24.86 %	$ 820 K	USA
BioLineRx Ltd. BLRX	-23.6 M	$ 3.03	2.35 %	$ 908 M	Israel
BioNTech SE BNTX	890 M	$ 117.93	-0.46 %	$ 27.2 B	Germany
Aeterna Zentaris AEZS	-8.58 M	-	5.93 %	$ 314 M	Canada
Alterity Therapeutics Limited ATHE	-12.3 M	$ 3.31	1.22 %	$ 7.96 B	Australia
BioXcel Therapeutics BTAI	-72 M	$ 1.83	0.83 %	$ 4.64 M	USA
AgeX Therapeutics AGE	-7.8 M	-	-10.17 %	$ 12.2 K	USA
Burford Capital Limited BUR	181 M	$ 9.64	-2.33 %	$ 1.58 B	Britain
Biophytis SA BPTS	-23.8 M	-	-13.47 %	$ 169 M	France
Can-Fite BioPharma Ltd. CANF	-7.64 M	$ 4.23	1.68 %	$ 9.2 B	Israel
Aeglea BioTherapeutics AGLE	-157 M	-	-	$ 1.01 B	USA
Amphastar Pharmaceuticals AMPH	213 M	$ 26.09	-0.21 %	$ 1.26 B	USA
Midatech Pharma plc MTP	-6.01 M	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	-230 M	-	-	$ 3.67 B	USA
Coherus BioSciences CHRS	-175 M	$ 2.03	27.67 %	$ 191 M	USA
Aptose Biosciences APTO	-36 M	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	-65.1 M	-	-13.39 %	$ 1.45 M	USA
Athira Pharma ATHA	-97.2 M	-	-	$ 269 M	USA
Akouos AKUS	-63.7 M	-	0.23 %	$ 488 M	USA
AVROBIO AVRO	-63.2 M	-	1083.1 %	$ 745 M	USA
Applied Molecular Transport AMTI	-93.9 M	-	-	$ 10.1 M	USA
Ascendis Pharma A/S ASND	-418 M	$ 230.76	0.92 %	$ 5 B	Danmark
ARCA biopharma ABIO	-57.8 M	-	1052.0 %	$ 415 M	USA
Aytu BioScience AYTU	-1.94 M	$ 2.72	0.37 %	$ 17.1 M	USA
Corcept Therapeutics Incorporated CORT	198 M	$ 42.02	1.74 %	$ 4.34 B	USA
Acasti Pharma ACST	-14.9 M	-	4.01 %	$ 150 M	Canada
Catalyst Pharmaceuticals CPRX	240 M	$ 24.23	-0.9 %	$ 2.87 B	USA
Arrowhead Pharmaceuticals ARWR	180 M	$ 70.82	1.77 %	$ 9.47 B	USA
Brickell Biotech BBI	-4.34 M	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	-141 M	-	0.49 %	$ 251 B	Cayman-islands
Champions Oncology CSBR	7.39 M	$ 6.9	-0.43 %	$ 94.3 M	USA
Ayala Pharmaceuticals AYLA	-34.5 M	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	-141 M	-	-15.15 %	$ 60.3 M	Britain
AIkido Pharma AIKI	-15.1 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	-108 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	-733 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	-30.3 M	-	2.71 %	$ 14 M	USA
Bellicum Pharmaceuticals BLCM	-25.8 M	-	-9.72 %	$ 5.89 M	USA
Alpine Immune Sciences ALPN	-43.8 M	-	-	$ 2.17 B	USA
AlloVir ALVR	-67.7 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-8.56 M	-	-11.43 %	$ 502 K	USA
Biogen BIIB	2.88 B	$ 171.66	-1.23 %	$ 25 B	USA
Bio-Path Holdings BPTH	-11.5 M	-	-	$ 100 K	USA
BioVie BIVI	-19 M	$ 1.26	0.79 %	$ 1.86 M	USA
Baudax Bio BXRX	-27.8 M	-	0.59 %	$ 63 K	USA